Bicara Therapeutics Inc. (BCAX)
NASDAQ: BCAX · Real-Time Price · USD
21.54
-0.84 (-3.78%)
May 13, 2026, 3:21 PM EDT - Market open
Bicara Therapeutics Employees
Bicara Therapeutics had 103 employees as of December 31, 2025. The number of employees increased by 48 or 87.27% compared to the previous year.
Employees
103
Change (1Y)
48
Growth (1Y)
87.27%
Revenue / Employee
n/a
Profits / Employee
-$1,527,330
Market Cap
1.41B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 103 | 48 | 87.27% |
| Dec 31, 2024 | 55 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Fortrea Holdings | 14,000 |
| Immatics | 711 |
| AbCellera Biologics | 562 |
| Immunocore Holdings | 524 |
| UroGen Pharma | 298 |
| KalVista Pharmaceuticals | 275 |
| Biohaven | 274 |
| Precigen | 160 |
BCAX News
- 3 hours ago - Bicara Therapeutics Transcript: Bank of America Global Healthcare Conference 2026 - Transcripts
- 6 hours ago - Bicara Therapeutics Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 1 day ago - Bicara Therapeutics price target raised to $37 from $36 at Morgan Stanley - TheFly
- 1 day ago - Bicara Therapeutics price target raised to $18 from $16 at Goldman Sachs - TheFly
- 2 days ago - Bicara Therapeutics reports Q1 EPS (93c), consensus (65c) - TheFly
- 2 days ago - Bicara Therapeutics Earnings Call Transcript: Q1 2026 - Transcripts
- 2 days ago - Bicara Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update - GlobeNewsWire
- 2 days ago - Bicara Therapeutics initiated with a Buy at Guggenheim - TheFly